Robert Schnoll, PhD
Associate Director for Population Science, Abramson Cancer Center Program Leader and Director, Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, Perelman School of Medicine
Courses Taught
PUBH 7090 Capstone II
Contact
Brief Bio
Dr. Schnoll is a Professor and Director of the Center for Interdisciplinary Research on Nicotine Addiction in the Department of Psychiatry, Associate Director for Population Science at the Abramson Cancer Center, and Senior Fellow at the Center for Public Health Initiatives at the University of Pennsylvania. After receiving his Ph.D. (psychology) from the University of Rhode Island in 1998, Dr. Schnoll completed a Cancer Prevention and Control fellowship at Fox Chase Cancer Center and remained there as faculty in the Division of Population Science until September, 2005, when he moved to Penn. Dr. Schnoll’s research focuses on: 1) Treating nicotine dependence in clinical populations such as smokers with HIV, cancer, or serious mental illness; 2) Understanding and promoting “best practices” for clinician-delivered tobacco treatments; and 3) Improving the effectiveness of pharmacotherapies for nicotine dependence through personalized or extended use of treatments.
Publications
- Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
- Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial
- The use of biomarkers to guide precision treatment for tobacco use
- Cluster Randomized Pragmatic Clinical Trial Testing Behavioral Economic Implementation Strategies to Improve Tobacco Treatment for Patients With Cancer Who Smoke